Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. nebu-one

NEBU-ONE

NEBU-ONE : A revolutionary method for anatomic pathology slides staining

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NEBU-ONE project word cloud

Explore the words cloud of the NEBU-ONE project. It provides you a very rough idea of what is the project "NEBU-ONE" about.

samples    expensive    200    innovative    processed    screening    cervical    apl    efficiency    events    pollutants    safety    cytological    milliard    form    cancers    aerosol    microdroplets    automation    transfer    tests    post    staining    capability    cross    optana    decreased    grow    laboratories    euros    market    lengthening    automated    technologies    responsibility    cancer    create    misinterpreted    heads    plan    breakthrough    deposits    laboratory    worldwide    30    economic    negative    techniques    anatomic    business    turnover    penetrate    contains    reference    apls    industrial    biological    leverage    diagnosis    nebulization    consumption    sustain    device    routine    deeper    65    quality    errors    reagents    model    accuracy    validate    double    faster    devastating    medical    interpretation    contamination    cell    million    standard    care    qualified    2020    cells    proprietary    lifetime    tissues    urgently    millions    misidentification    feasibility    modernize    patient    pathology    tested    nebu   

Project "NEBU-ONE" data sheet

The following table provides information about the project.

Coordinator		 OPTANA TECHNOLOGIES 

Organization address
address: 180 RUE D ESTIENNE D ORVES
city: COLOMBES
postcode: 92700
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-03-01   to  2016-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OPTANA TECHNOLOGIES FR (COLOMBES) coordinator 50˙000.00

Map

 Project objective

Anatomic pathology laboratories (APL) across Europe have a responsibility to urgently modernize and sustain increasing efficiency, leverage automation, and foster patient safety. Misidentification errors in laboratories have the capability to cause devastating events, both at medical and economic level. It is estimated that 30% of cytological cell samples are misinterpreted as negative for cancer. That represents 1.65 millions of samples per year. One of the most important problems for APL is the increase of the number of biological screening samples to be processed due to the lengthening of the lifetime and increased number of cancers. Only screening of cervical cancer, which represents today about 200 million tests worldwide and the market of about 1 milliard of euros, should double by 2020. Optana Technologies is developing a breakthrough medical device called NEBU-ONE, for highly improved and automated biological sample staining. NEBU-ONE contains a proprietary “nebulization heads” which deposits staining reagents in the form of aerosol (microdroplets) allowing them to penetrate much deeper and much faster into the tested samples (cells and tissues) compared to standard techniques. Often present cross-contamination between samples will be also decreased, as well as a consumption of expensive and pollutants reagents. All these will lead to increased quality of sample staining, improved accuracy of the analysis and interpretation and better diagnosis and patient care. It will allow Optana Technologies to become the reference method in the APLs and to grow rapidly in the European market. We plan to achieve the turnover of 4.3 M€ in 2020 and create 5 new highly qualified post. This feasibility study is essential to validate our innovative business model and NEBU-ONE before its transfer in routine laboratory practice and industrial production.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEBU-ONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEBU-ONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More